Selective expression of foreign genes in glioma cells: Use of the mouse myelin basic protein gene promoter to direct toxic gene expression

Y. Miyao, K. Shimizu, S. Moriuchi, M. Yamada, K. Nakahira, Kazunori Nakajima, J. Nakao, S. Kuriyama, T. Tsujii, K. Mikoshiba, T. Hayakawa, K. Ikenaka

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

We have previously demonstrated that retrovirus-mediated genes were transferred to mouse glioma cells in a meningeal gliomatosis model (Yamada et al.: Japanese Journal of Cancer Research 83:1244-1247, 1992). This retrovirus vector contains the Escherichia coli. β-galactosidase (β-gal) gene as a marker for integration of the lacZ gene, which is controlled by the SV40 early promoter. We investigated whether lacZ genes could be specifically controlled in mouse glioma cells by glial-specific promoters, including the 2.5 kb 5' flanking region of the mouse glial fibrillary acidic protein (GFAP) gene, the 1.3 kb 5' flanking region of the myelin basic protein (MBP) gene, and the 1.5 kb 5' flanking region of the myelin proteolipid protein (PLP) gene. Psi-2 packaging cells were transfected with each retrovirus vector (GFAP promoter-, MBP promoter-, and PLP promoter-lacZ) and the infectious virus particles were recovered from the supernatants. Blue staining for β- gal was detected in various fibroblast, myeloma, and glioma cell lines transduced with the retrovirus BAG vector. On the other hand, blue staining was only detected in glioma cells after transduction with the lacZ gene- bearing retrovirus controlled by glial-specific promoters. The strongest promoter activity was detected after transduction with the retrovirus in which the MBP promoter controlled the lacZ gene. Mouse glioma cells transduced with retrovirus containing the MBP promoter directing the herpes simplex virus type 1 thymidine kinase (HTK) gene were extremely sensitive to ganciclovir, while the parental cells and cells transduced with retrovirus containing the lacZ gene were not sensitive to ganciclovir. Furthermore, none of the nonglioma cells tested was sensitive to ganciclovir, even when transduced with the MBP promoter-HTK gene-containing retrovirus. In conclusion, retrovirus-targeted gene therapy of malignant glioma may be applicable with a low risk of side effects such as bone marrow suppression, in contrast to chemotherapy or the use of retroviruses bearing toxic genes controlled by nonspecific promoters.

Original languageEnglish
Pages (from-to)472-479
Number of pages8
JournalJournal of Neuroscience Research
Volume36
Issue number4
DOIs
Publication statusPublished - 1993
Externally publishedYes

Fingerprint

Poisons
Retroviridae
Glioma
Gene Expression
Lac Operon
Myelin Basic Protein
Genes
Ganciclovir
5' Flanking Region
Glial Fibrillary Acidic Protein
Neuroglia
Mouse Mbp protein
Myelin Proteolipid Protein
Galactosidases
Staining and Labeling
Proteolipids
Thymidine Kinase
Human Herpesvirus 1
Product Packaging
Genetic Therapy

Keywords

  • ganciclovir
  • gene therapy
  • malignant glioma
  • MBP promoter

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Selective expression of foreign genes in glioma cells : Use of the mouse myelin basic protein gene promoter to direct toxic gene expression. / Miyao, Y.; Shimizu, K.; Moriuchi, S.; Yamada, M.; Nakahira, K.; Nakajima, Kazunori; Nakao, J.; Kuriyama, S.; Tsujii, T.; Mikoshiba, K.; Hayakawa, T.; Ikenaka, K.

In: Journal of Neuroscience Research, Vol. 36, No. 4, 1993, p. 472-479.

Research output: Contribution to journalArticle

Miyao, Y, Shimizu, K, Moriuchi, S, Yamada, M, Nakahira, K, Nakajima, K, Nakao, J, Kuriyama, S, Tsujii, T, Mikoshiba, K, Hayakawa, T & Ikenaka, K 1993, 'Selective expression of foreign genes in glioma cells: Use of the mouse myelin basic protein gene promoter to direct toxic gene expression', Journal of Neuroscience Research, vol. 36, no. 4, pp. 472-479. https://doi.org/10.1002/jnr.490360413
Miyao, Y. ; Shimizu, K. ; Moriuchi, S. ; Yamada, M. ; Nakahira, K. ; Nakajima, Kazunori ; Nakao, J. ; Kuriyama, S. ; Tsujii, T. ; Mikoshiba, K. ; Hayakawa, T. ; Ikenaka, K. / Selective expression of foreign genes in glioma cells : Use of the mouse myelin basic protein gene promoter to direct toxic gene expression. In: Journal of Neuroscience Research. 1993 ; Vol. 36, No. 4. pp. 472-479.
@article{a4a61222cc774b009fa3310563158b6a,
title = "Selective expression of foreign genes in glioma cells: Use of the mouse myelin basic protein gene promoter to direct toxic gene expression",
abstract = "We have previously demonstrated that retrovirus-mediated genes were transferred to mouse glioma cells in a meningeal gliomatosis model (Yamada et al.: Japanese Journal of Cancer Research 83:1244-1247, 1992). This retrovirus vector contains the Escherichia coli. β-galactosidase (β-gal) gene as a marker for integration of the lacZ gene, which is controlled by the SV40 early promoter. We investigated whether lacZ genes could be specifically controlled in mouse glioma cells by glial-specific promoters, including the 2.5 kb 5' flanking region of the mouse glial fibrillary acidic protein (GFAP) gene, the 1.3 kb 5' flanking region of the myelin basic protein (MBP) gene, and the 1.5 kb 5' flanking region of the myelin proteolipid protein (PLP) gene. Psi-2 packaging cells were transfected with each retrovirus vector (GFAP promoter-, MBP promoter-, and PLP promoter-lacZ) and the infectious virus particles were recovered from the supernatants. Blue staining for β- gal was detected in various fibroblast, myeloma, and glioma cell lines transduced with the retrovirus BAG vector. On the other hand, blue staining was only detected in glioma cells after transduction with the lacZ gene- bearing retrovirus controlled by glial-specific promoters. The strongest promoter activity was detected after transduction with the retrovirus in which the MBP promoter controlled the lacZ gene. Mouse glioma cells transduced with retrovirus containing the MBP promoter directing the herpes simplex virus type 1 thymidine kinase (HTK) gene were extremely sensitive to ganciclovir, while the parental cells and cells transduced with retrovirus containing the lacZ gene were not sensitive to ganciclovir. Furthermore, none of the nonglioma cells tested was sensitive to ganciclovir, even when transduced with the MBP promoter-HTK gene-containing retrovirus. In conclusion, retrovirus-targeted gene therapy of malignant glioma may be applicable with a low risk of side effects such as bone marrow suppression, in contrast to chemotherapy or the use of retroviruses bearing toxic genes controlled by nonspecific promoters.",
keywords = "ganciclovir, gene therapy, malignant glioma, MBP promoter",
author = "Y. Miyao and K. Shimizu and S. Moriuchi and M. Yamada and K. Nakahira and Kazunori Nakajima and J. Nakao and S. Kuriyama and T. Tsujii and K. Mikoshiba and T. Hayakawa and K. Ikenaka",
year = "1993",
doi = "10.1002/jnr.490360413",
language = "English",
volume = "36",
pages = "472--479",
journal = "Journal of Neuroscience Research",
issn = "0360-4012",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Selective expression of foreign genes in glioma cells

T2 - Use of the mouse myelin basic protein gene promoter to direct toxic gene expression

AU - Miyao, Y.

AU - Shimizu, K.

AU - Moriuchi, S.

AU - Yamada, M.

AU - Nakahira, K.

AU - Nakajima, Kazunori

AU - Nakao, J.

AU - Kuriyama, S.

AU - Tsujii, T.

AU - Mikoshiba, K.

AU - Hayakawa, T.

AU - Ikenaka, K.

PY - 1993

Y1 - 1993

N2 - We have previously demonstrated that retrovirus-mediated genes were transferred to mouse glioma cells in a meningeal gliomatosis model (Yamada et al.: Japanese Journal of Cancer Research 83:1244-1247, 1992). This retrovirus vector contains the Escherichia coli. β-galactosidase (β-gal) gene as a marker for integration of the lacZ gene, which is controlled by the SV40 early promoter. We investigated whether lacZ genes could be specifically controlled in mouse glioma cells by glial-specific promoters, including the 2.5 kb 5' flanking region of the mouse glial fibrillary acidic protein (GFAP) gene, the 1.3 kb 5' flanking region of the myelin basic protein (MBP) gene, and the 1.5 kb 5' flanking region of the myelin proteolipid protein (PLP) gene. Psi-2 packaging cells were transfected with each retrovirus vector (GFAP promoter-, MBP promoter-, and PLP promoter-lacZ) and the infectious virus particles were recovered from the supernatants. Blue staining for β- gal was detected in various fibroblast, myeloma, and glioma cell lines transduced with the retrovirus BAG vector. On the other hand, blue staining was only detected in glioma cells after transduction with the lacZ gene- bearing retrovirus controlled by glial-specific promoters. The strongest promoter activity was detected after transduction with the retrovirus in which the MBP promoter controlled the lacZ gene. Mouse glioma cells transduced with retrovirus containing the MBP promoter directing the herpes simplex virus type 1 thymidine kinase (HTK) gene were extremely sensitive to ganciclovir, while the parental cells and cells transduced with retrovirus containing the lacZ gene were not sensitive to ganciclovir. Furthermore, none of the nonglioma cells tested was sensitive to ganciclovir, even when transduced with the MBP promoter-HTK gene-containing retrovirus. In conclusion, retrovirus-targeted gene therapy of malignant glioma may be applicable with a low risk of side effects such as bone marrow suppression, in contrast to chemotherapy or the use of retroviruses bearing toxic genes controlled by nonspecific promoters.

AB - We have previously demonstrated that retrovirus-mediated genes were transferred to mouse glioma cells in a meningeal gliomatosis model (Yamada et al.: Japanese Journal of Cancer Research 83:1244-1247, 1992). This retrovirus vector contains the Escherichia coli. β-galactosidase (β-gal) gene as a marker for integration of the lacZ gene, which is controlled by the SV40 early promoter. We investigated whether lacZ genes could be specifically controlled in mouse glioma cells by glial-specific promoters, including the 2.5 kb 5' flanking region of the mouse glial fibrillary acidic protein (GFAP) gene, the 1.3 kb 5' flanking region of the myelin basic protein (MBP) gene, and the 1.5 kb 5' flanking region of the myelin proteolipid protein (PLP) gene. Psi-2 packaging cells were transfected with each retrovirus vector (GFAP promoter-, MBP promoter-, and PLP promoter-lacZ) and the infectious virus particles were recovered from the supernatants. Blue staining for β- gal was detected in various fibroblast, myeloma, and glioma cell lines transduced with the retrovirus BAG vector. On the other hand, blue staining was only detected in glioma cells after transduction with the lacZ gene- bearing retrovirus controlled by glial-specific promoters. The strongest promoter activity was detected after transduction with the retrovirus in which the MBP promoter controlled the lacZ gene. Mouse glioma cells transduced with retrovirus containing the MBP promoter directing the herpes simplex virus type 1 thymidine kinase (HTK) gene were extremely sensitive to ganciclovir, while the parental cells and cells transduced with retrovirus containing the lacZ gene were not sensitive to ganciclovir. Furthermore, none of the nonglioma cells tested was sensitive to ganciclovir, even when transduced with the MBP promoter-HTK gene-containing retrovirus. In conclusion, retrovirus-targeted gene therapy of malignant glioma may be applicable with a low risk of side effects such as bone marrow suppression, in contrast to chemotherapy or the use of retroviruses bearing toxic genes controlled by nonspecific promoters.

KW - ganciclovir

KW - gene therapy

KW - malignant glioma

KW - MBP promoter

UR - http://www.scopus.com/inward/record.url?scp=0027363115&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027363115&partnerID=8YFLogxK

U2 - 10.1002/jnr.490360413

DO - 10.1002/jnr.490360413

M3 - Article

C2 - 7505843

AN - SCOPUS:0027363115

VL - 36

SP - 472

EP - 479

JO - Journal of Neuroscience Research

JF - Journal of Neuroscience Research

SN - 0360-4012

IS - 4

ER -